Zepto DRHP flags ₹577 cr secondary sale as Nexus, Kaiser trim stakes pre-IPO
Zepto's draft prospectus reveals an August 2025 secondary share sale worth ₹577 crore, with Motilal Oswal Financial Services absorbing exits from Nexus Venture (₹356 cr), Kaiser Permanente (₹190 cr) and Razor Ventures (₹31 cr). Founders Palicha and Vohra retain 1.07% and 0.89% directly, with trust holdings of 9.03% and 7.48%.
What happened
Zepto's DRHP discloses a ₹577 crore secondary share sale in August 2025, with Motilal Oswal buying stakes from Nexus Venture, Kaiser Permanente and Razor
Key facts
- ₹577 crore secondary sale
- ₹356 crore Nexus exit
- ₹190 crore Kaiser exit
- ₹31 crore Razor Ventures
- Palicha 1.07%
- Vohra 0.89%
- Lazarus Trust 9.03%
- Vohra Trust 7.48%
Why this matters
Zepto's structured ₹577 cr secondary with a single domestic absorber offers a template for late-stage quick commerce exits, and founder trust structures retaining ~16% combined signal how Indian consumer founders are ring-fencing control ahead of public listings.